These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 19391498)

  • 1. [Directions of investigations for new drugs in asthma].
    Płusa T
    Pol Merkur Lekarski; 2009 Jan; 26(151):5-8. PubMed ID: 19391498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends and directions in the rationalization of pharmacotherapy of bronchial asthma: probing for alternatives.
    Das BP; Sethi A
    Kathmandu Univ Med J (KUMJ); 2006; 4(3):368-78. PubMed ID: 18603937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New targets for drug development in asthma.
    Adcock IM; Caramori G; Chung KF
    Lancet; 2008 Sep; 372(9643):1073-87. PubMed ID: 18805336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of bronchial asthma in adults. Current advances].
    Caramori G; Contoli M; Papi A
    Recenti Prog Med; 2009 Apr; 100(4):171-9. PubMed ID: 19554915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "As-required" combination therapy with inhaled corticosteroids and long-acting beta-2 agonists for asthma: current evidence and recommendations.
    Taylor DR; Jayaram L; Asher MI; Epton MJ
    N Z Med J; 2008 Nov; 121(1285):106-18. PubMed ID: 19079443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic therapies for asthma.
    Gruenberg D; Busse W
    Curr Opin Pulm Med; 2010 Jan; 16(1):19-24. PubMed ID: 19797955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
    Kopriva F; Dzubak P; Potesil J; Hajduch M
    J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can corticosteroids be beaten in future asthma therapy?
    Amon A; Pahl A; Szelenyi I
    Pharmazie; 2006 Feb; 61(2):122-4. PubMed ID: 16526559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory and biologic therapies for severe refractory asthma.
    Polosa R; Morjaria J
    Respir Med; 2008 Nov; 102(11):1499-510. PubMed ID: 19012848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic therapies for the treatment of asthma.
    Wagelie-Steffen AL; Kavanaugh AF; Wasserman SI
    Clin Chest Med; 2006 Mar; 27(1):133-47, vii. PubMed ID: 16543058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in the treatment of asthma.
    Douglas G
    Practitioner; 2007 Nov; 251(1700):30, 33-6. PubMed ID: 18087983
    [No Abstract]   [Full Text] [Related]  

  • 13. [American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
    Lichtenstein GR; Sbreu MT; Cohen R; Tremaine W
    Rev Gastroenterol Mex; 2006; 71(3):351-401. PubMed ID: 17140062
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of leukotriene receptor antagonists and synthesis inhibitors in asthma.
    O'Byrne PM; Gauvreau GM; Murphy DM
    J Allergy Clin Immunol; 2009 Sep; 124(3):397-403. PubMed ID: 19608262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X; Gutierrez B; Zarotsky V; Nelson M; Blanchette CM
    Curr Med Res Opin; 2009 Sep; 25(9):2251-8. PubMed ID: 19622006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulators for allergic respiratory disorders.
    Casale TB; Stokes JR
    J Allergy Clin Immunol; 2008 Feb; 121(2):288-96; quiz 297-8. PubMed ID: 18269921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [TNF-blockade--new strategy in difficult-to-treat asthma].
    Dahlén SE; Millinger E; Skedinger M; Zetterström O; Dahlén B
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1946-8. PubMed ID: 18681378
    [No Abstract]   [Full Text] [Related]  

  • 18. Omalizumab and Churg-Strauss syndrome.
    Giavina-Bianchi P; Giavina-Bianchi M; Agondi R; Kalil J
    J Allergy Clin Immunol; 2008 Jul; 122(1):217; author reply 217-8. PubMed ID: 18602576
    [No Abstract]   [Full Text] [Related]  

  • 19. Overcoming steroid insensitivity in smoking asthmatics.
    Ahmad T; Barnes PJ; Adcock IM
    Curr Opin Investig Drugs; 2008 May; 9(5):470-7. PubMed ID: 18465656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response modifiers in the treatment of asthma: A PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology.
    Ballow M; Akdis CA; Casale TB; Wardlaw AJ; Wenzel SE; Ballas Z; Lötvall J
    J Allergy Clin Immunol; 2012 Aug; 130(2):311-24. PubMed ID: 22713596
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.